| Descriptor English: | Vidarabine | ||||||
| Descriptor Spanish: |
Vidarabina
| ||||||
| Descriptor Portuguese: | Vidarabina | ||||||
| Descriptor French: | Vidarabine | ||||||
| Entry term(s): |
9 beta Arabinofuranosyladenine 9 beta D Arabinofuranosyladenine 9-beta-Arabinofuranosyladenine 9-beta-D-Arabinofuranosyladenine Adenine Arabinoside Ara A Ara-A Arabinofuranosyladenine Arabinoside, Adenine Arabinosyladenine Vira A Vira-A ViraA alpha Ara A alpha D Arabinofuranosyladenine alpha-Ara A alpha-D-Arabinofuranosyladenine beta Ara A beta-Ara A |
||||||
| Tree number(s): |
D03.633.100.759.590.138.900 D13.570.065.950 D13.570.583.138.900 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D014740 | ||||||
| Scope note: | A nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the VACCINIA VIRUS and varicella zoster virus. |
||||||
| Annotation: | an antiviral & antimetabolite |
||||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Pharm Action: |
Antimetabolites Antiviral Agents |
||||||
| Registry Number: | FA2DM6879K | ||||||
| CAS Type 1 Name: | 9H-Purin-6-amine, 9-beta-D-arabinofuranosyl- | ||||||
| Previous Indexing: |
Adenine (1972-1974) Arabinose (1972-1974) Nucleosides (1972-1974) Purines (1966-1973) |
||||||
| Public MeSH Note: | 79; was ARABINOFURANOSYLADENINE 1977-78, was ARABINOFURANOSYLADENINE see under PURINE NUCLEOSIDES 1975-76 |
||||||
| Online Note: | use VIDARABINE to search ARABINOFURANOSYLADENINE 1975-78 |
||||||
| History Note: | 79; was ARABINOFURANOSYLADENINE 1977-78, was ARABINOFURANOSYLADENINE see under PURINE NUCLEOSIDES 1975-76 |
||||||
| DeCS ID: | 15144 | ||||||
| Unique ID: | D014740 | ||||||
| NLM Classification: | QV 268.5 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1977/01/01 | ||||||
| Date of Entry: | 1974/11/19 | ||||||
| Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
|
Vidarabine
- Preferred
Vira-A
- Narrower
| Concept UI |
M0022659 |
| Scope note | A nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the VACCINIA VIRUS and varicella zoster virus. |
| Preferred term | Vidarabine |
| Entry term(s) |
9 beta Arabinofuranosyladenine 9 beta D Arabinofuranosyladenine 9-beta-Arabinofuranosyladenine 9-beta-D-Arabinofuranosyladenine Adenine Arabinoside Ara A Ara-A Arabinofuranosyladenine Arabinoside, Adenine Arabinosyladenine alpha Ara A alpha D Arabinofuranosyladenine alpha-Ara A alpha-D-Arabinofuranosyladenine beta Ara A beta-Ara A |
| Concept UI |
M0022660 |
| Preferred term | Vira-A |
| Entry term(s) |
Vira A ViraA |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
